Clinical Trial Update: Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder [NA]

View source ↗

Summary

A completed clinical trial explored adding an NMDA receptor agonist to exposure therapy for Panic Disorder to improve treatment outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Snippet

Sponsor: Hartford Hospital | Conditions: Panic Disorder | NA | Status: COMPLETED